Apellis posts results of Pegcetacoplan long-term safety extension study
The study, completed on September 4, 2025, enrolled 137 participants who had previously completed a pegcetacoplan study. It was an open-label, non-randomized, multi-center Phase 3 extension study evaluating long-term safety and efficacy in PNH.
Primary source
ClinicalTrials.gov results record, November 10, 2026
Pegcetacoplan Long Term Safety and Efficacy Extension Study
Read the source: Pegcetacoplan Long Term Safety and Efficacy Extension Study clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation